Medvest

Medvest is a UK-based company that has invested in Israeli medtech and digital health products, focusing on bringing safe and efficient products to market through local partnerships.

Angel Group Active null, United Kingdom Est. 2006
Visit website ↗ LinkedIn
Last updated 2026-07-20
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
0
Rounds' value
$600K
total disclosed, rounds participated
Stages
A Round, Seed, Pre-Seed, B Round

About

Medvest is a UK-based company that invests in Israeli medtech and digital health products. Their focus is on delivering safety and efficiency through big data analytics and enhanced patented technologies. They have invested in both hospital products and digital health products based on home care and lifestyle health tracking. Medvest aims to accelerate products to commercialization through a common ecosystem, achieve significant shareholdings in portfolio companies for higher ROI on exits, and expand offerings through product development and acquisitions. The company also emphasizes creating sustainable and recyclable products that conform to ESG standards.

Portfolio · 1

LunGuard
Reflux Prevention Device for Ventilated and Tube-fed Patients
1 round $600K committed Latest: 2009-01

Investment activity

1 portfolio exit on record.

Portfolio by sector

Health Tech & Life Sciences4

Funds · 1

  • 3 — $650K Jun 2020

Q&A

What is Medvest's primary investment focus?
Medvest is a UK-based company that invests in Israeli medtech and digital health products, focusing on safety and efficiency through big data analytics and enhanced patented technologies.
Can you name some of Medvest's portfolio companies?
Medvest's portfolio includes CardioSert, which develops advanced tools for interventional cardiologists, and Rapidx, which focuses on at-home rapid diagnostic tests.
What is Medvest's investment stage preference?
Medvest invests across various stages, including Pre-Seed, Seed, A Round, and B Round.
Has Medvest had any notable exits?
Yes, Medvest had an exit in May 2018 when its portfolio company CardioSert was acquired by Microbot Medical for $370K.
What is Medvest's geographic focus for investments?
Medvest specifically invests in Israeli medtech and digital health products, with a focus on bringing these products to as many markets as possible through local partnerships.
What is Medvest's approach to portfolio company development?
Medvest aims to accelerate products to commercialization through a common ecosystem, achieve significant or controlling shareholdings for larger returns on exits, and expand offerings through product development and acquisitions.
Who are the key individuals on Medvest's team?
The key individuals on Medvest's team include Avi Azulai, Founder & Managing Partner, and Joaquin Gari and David Akunis, both Managing Partners.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)